Conferences and Events > Previous Conferences and Events > 2017 Conferences and Events > 23rd Annual Conference of the British HIV Association (Liverpool 2017) > 23rd Annual Conference of BHIVA - Presentations > 23rd Annual Conference of BHIVA Presentations - Wednesday 5 April 2017 >

MRC Clinical Trials Unit Session - 23rd Annual Conference of BHIVA

The motion: This house believes that efavirenz should remain as an option to treat HIV in the UK

Dr Sarah Pett For the motion: Dr Sarah Pett
MRC Clinical Trials Unit, London

Dr Alejandro Arenas-Pinto Against the motion: Dr Alejandro Arenas-Pinto
MRC Clinical Trials Unit, London
 

Click here to go back to all presentations.